Latest Share Chat

REMOVE ADS

AKR.L Regulatory News (AKR)

AKR.L Information

There is currently no data for AKR

REMOVE ADS

Result of AGM

13 Jul 2009 17:29

RNS Number : 5943V

Akers Biosciences, Inc.

13 July 2009

For immediate release: 13 July 2009

Akers Biosciences, Inc.

(the "Company")

Result of Annual General Meeting

Akers Biosciences, Inc. (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that all resolutions proposed at the Annual General Meeting of the Company, held today, were duly passed.

For further information please contact:

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

Ben Simons

M: Communications

Tel. +44 (0)20 7153 1540

Alasdair Younie

Arbuthnot Securities Limited

Tel. +44 (0)20 7012 2000

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGRJMFTMMTBBLL

Date		Source	Headline
6th Mar 2019	7:00 am	RNS	Result of Special Meeting of Shareholders
6th Feb 2019	9:00 am	RNS	Holding in Company
6th Feb 2019	7:01 am	RNS	Form DEFA14A Filing - Additional Proxy Materials
6th Feb 2019	7:00 am	RNS	Notice of Special Meeting of Shareholders
5th Feb 2019	1:00 pm	RNS	Further Re. Directorate Change
28th Jan 2019	7:00 am	RNS	Form PRE 14A Filing
28th Dec 2018	3:45 pm	RNS	Director/PDMR Shareholding
19th Dec 2018	4:45 pm	RNS	Intention to Delist from AIM
18th Dec 2018	6:00 pm	RNS	Issue of Equity
10th Dec 2018	7:00 am	RNS	Result of AGM & Form 8-K Filing
26th Nov 2018	2:00 pm	RNS	Further Re. Notice of AGM
19th Nov 2018	2:00 pm	RNS	Further Re. Strategic Update
16th Nov 2018	4:00 pm	RNS	Reverse Stock Split Update
15th Nov 2018	7:00 am	RNS	Notice of AGM
15th Nov 2018	7:00 am	RNS	3rd Quarter 2018 Results
12th Nov 2018	7:00 am	RNS	Form 8-K Filing
8th Nov 2018	7:30 am	RNS	Suspension - Akers Biosciences, Inc.
8th Nov 2018	7:00 am	RNS	Temporary Suspension of Share Trading on LSE
7th Nov 2018	2:50 pm	RNS	Strategic Update & Reverse Stock Split
2nd Nov 2018	4:15 pm	RNS	Issue of Equity - Completion & Form 8-K/A Filing
2nd Nov 2018	10:52 am	RNS	Update Re Issue of Equity
31st Oct 2018	1:35 pm	RNS	Issue of Equity & Form 8-K
19th Oct 2018	2:53 pm	RNS	Form 8-K Filing
19th Oct 2018	7:00 am	RNS	Directorate Change
12th Oct 2018	7:00 am	RNS	Form 8-K/A Filing & Other Updates
8th Oct 2018	7:00 am	RNS	Directorate Change & Other Information
13th Sep 2018	7:00 am	RNS	Directorate Change - Form 8-K Filing
15th Aug 2018	7:00 am	RNS	2nd Quarter & H1 2018 Results
27th Jul 2018	3:00 pm	RNS	Holding(s) in Company
26th Jul 2018	7:30 am	RNS	Restoration - Akers Biosciences Inc.
26th Jul 2018	7:00 am	RNS	Mailing of 2017 Annual Report
20th Jul 2018	3:05 pm	RNS	Issue of Equity
20th Jul 2018	3:00 pm	RNS	Correction: Issue of Equity
18th Jul 2018	12:00 pm	RNS	Independent Sales Representative Agreements - PIFA
16th Jul 2018	7:03 am	RNS	1st Quarter 2018 Results
16th Jul 2018	7:02 am	RNS	Final Results 2017 (Restated)
16th Jul 2018	7:01 am	RNS	3rd Quarter 2017 Results (Restated)
16th Jul 2018	7:00 am	RNS	2nd Quarter 2017 Results (Restated)
3rd Jul 2018	12:00 pm	RNS	Independent Sales Representative Agreements - PIFA
2nd Jul 2018	7:30 am	RNS	Suspension - Akers Bioscience, Inc
29th Jun 2018	7:00 am	RNS	Temporary Suspension
21st Jun 2018	7:00 am	RNS	Notification of Class Action
20th Jun 2018	7:22 am	RNS	Form 8-K Filing
18th Jun 2018	7:00 am	RNS	Form 8-K Filing
6th Jun 2018	7:00 am	RNS	Form 8-K/A Filing
4th Jun 2018	7:00 am	RNS	Form 8-K Filing
31st May 2018	7:25 am	RNS	Update Re. Nasdaq Minimum Bid Price Requirement
29th May 2018	7:00 am	RNS	Directorate Change
29th May 2018	7:00 am	RNS	Withdrawal of 510(k) Submission - Chlamydia Assay
29th May 2018	7:00 am	RNS	Notice of Form 10-Q Filing Delinquency from Nasdaq

Latest Share Chat

AKR.L Regulatory News (AKR)

Result of AGM

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending